viru
penetr
cell
rna
mole
cule
releas
capsid
trigger
cascad
event
result
format
matur
viral
progeni
even
tualli
cell
death
event
begin
synthesi
viral
protein
ie
translat
viral
rna
cellular
translat
system
express
viral
gene
often
regul
level
initi
mrna
tran
lation
step
ribosom
subunit
bind
mrna
scan
direct
reach
start
codon
ribosom
assem
bled
variou
host
protein
ci
act
rna
molecul
particip
process
cap
structur
present
terminu
eukaryot
mrna
par
ticip
captur
ribosom
subunit
scan
ning
mechan
impli
ribosom
initi
translat
first
aug
codon
case
mrna
howev
first
aug
codon
may
ignor
non
optim
sequenc
context
case
translat
initi
next
aug
codon
initi
mechan
refer
leaki
scan
biochemistri
moscow
vol
realiz
mani
virus
allow
save
code
sequenc
length
picornaviru
mrna
ssrna
virus
lack
cap
structur
demonstr
initi
translat
uncap
mrna
implement
via
structur
featur
mrna
molecul
allow
assembl
translat
apparatu
near
start
codon
stabl
secondari
structur
element
call
intern
ribosom
entri
site
iress
sinc
cap
independ
translat
initi
pathway
extens
studi
discoveri
overturn
major
dogma
translat
initi
state
eukaryot
ribosom
bind
mrna
exclus
terminu
iress
usual
situat
untran
late
region
frequent
complex
secondari
tertiari
structur
sinc
element
discov
picornavirus
also
found
sever
viral
mrna
mechan
ire
depend
tran
lation
presum
exploit
cellular
mrna
translat
mrna
continu
cap
depend
translat
repress
may
happen
endoplasm
reticulum
stress
hypoxia
starv
nutrient
mitosi
cell
differenti
addit
mention
picornavirus
initia
tion
translat
intern
site
util
represen
tativ
flavivirida
retrovirida
dicistrovirida
herpesvirida
insect
virus
plant
virus
also
retrotransposon
insect
rodent
howev
appear
unlik
cap
depend
translat
initi
scan
common
mechan
function
iress
furthermor
iress
differ
structur
element
found
share
iress
sequenc
also
lack
signific
homolog
howev
shown
major
viral
iress
stabl
sec
ondari
tertiari
structur
facilit
effici
bind
subunit
bind
either
direct
requir
particip
addit
canon
translat
initi
factor
along
host
protein
refer
itaf
ire
tran
act
factor
possibl
itaf
directli
particip
spe
cific
interact
mrna
subunit
wherea
other
stabil
specif
function
activ
ire
confor
mation
unlik
viral
mrna
exist
ire
depend
translat
cellular
mrna
cur
rentli
vigor
discuss
sinc
discoveri
viral
iress
difficulti
classif
arisen
due
dissimilar
howev
extens
studi
virus
mrna
mechan
translat
reveal
sever
common
featur
may
use
clearli
distinguish
ire
type
viral
iress
classifi
accord
sequenc
secondari
structur
divid
separ
famili
intergen
iress
dicistrovirus
invertebr
dicistrovirida
famili
instanc
cricket
paralysi
viru
ire
hepati
ti
c
hcv
relat
virus
anim
flavivirida
famili
iress
picornavirus
turn
divid
five
class
v
besid
poli
purin
rich
iress
par
ire
type
first
discov
tobamoviru
howev
return
review
picornaviru
iress
picornaviru
type
iress
includ
iress
represen
tativ
genu
enteroviru
singl
repres
genu
harkaviru
length
ire
approxim
nucleotid
nt
compris
domain
two
six
fig
contain
yn
xm
aug
ter
minu
yn
pyrimidin
sequenc
n
nt
x
linker
yn
aug
triplet
nt
motif
consid
region
ribosom
bind
utr
separ
start
codon
non
conserv
region
whose
length
rang
nt
rhinovirus
nt
polioviru
conserv
function
import
nucleotid
situat
base
second
domain
cru
ciform
fourth
domain
fifth
domain
specif
bind
fifth
domain
rna
helicas
promot
bind
com
plex
ire
translat
initi
studi
type
iress
depend
presenc
itaf
whose
complet
list
yet
determin
fig
initi
translat
type
ii
ire
requir
specif
bind
factor
domain
j
k
time
iress
function
without
factor
par
ticip
ribosom
scan
henc
type
ii
ire
differ
type
ire
lack
itaf
requir
one
except
demonstrat
ed
certain
case
cellular
rna
bind
protein
ptb
pyrimidin
bind
protein
requir
fig
type
iii
ire
found
hepat
viru
around
nt
long
iress
type
signifi
cantli
differ
first
two
type
sequenc
structur
element
effici
translat
initia
tion
ire
consider
lower
compar
first
two
ire
type
hepat
ire
requir
host
cap
bind
protein
function
though
exact
reason
clear
fig
type
iv
ire
found
repres
gen
era
kobuviru
aichiviru
c
porcin
kobuviru
fig
recent
type
v
ire
discov
found
repres
genera
osciviru
kobuviru
aichiviru
aichiviru
b
saliviru
type
ire
hybrid
central
domain
homolog
fourth
domain
type
iress
wherea
next
domain
bind
homolog
domain
j
type
ii
iress
start
codon
viral
polyprotein
part
yn
xm
aug
motif
situat
stabl
hairpin
domain
l
translat
initi
iress
requir
particip
atp
depend
rna
helicas
ptb
set
canon
factor
fig
simplest
mechan
translat
initi
hallmark
intergen
nt
long
ire
represen
tativ
dicistrovirus
instanc
intergen
ire
cricket
paralysi
viru
like
hepat
c
ire
form
complex
trna
like
structur
bind
directli
ribosom
p
site
trigger
initi
without
involv
eukaryot
translat
initi
factor
fig
modern
classif
enterovirus
accept
publish
updat
issu
viru
taxonomi
intern
committe
taxonomi
virus
sinc
correc
tion
classif
issu
present
genu
enteroviru
belong
famili
picornavirida
includ
nine
enteroviru
speci
name
enteroviru
b
c
e
f
g
h
j
three
rhi
noviru
speci
rhinoviru
b
c
new
enteroviru
discov
camel
appar
first
repres
new
speci
enteroviru
fig
speci
enteroviru
includ
sero
type
coxsackieviru
cv
cv
cv
cv
cv
cv
cv
cv
cv
cv
cv
enteroviru
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
simian
enterovirus
baboon
enteroviru
speci
enteroviru
b
one
numer
ou
consist
sero
type
coxsackieviru
cv
cv
echoviru
e
e
e
e
e
e
e
e
e
e
enteroviru
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
chimpanze
ev
ev
chimpanze
ev
mandril
simian
enteroviru
speci
enteroviru
c
includ
sero
type
polioviru
pv
pv
pv
coxsackieviru
cv
cv
cv
cv
cv
cv
cv
cv
cv
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
ev
speci
enteroviru
rel
uncommon
includ
five
sero
type
ev
ev
ev
ev
human
chimpanze
ev
gorilla
speci
enteroviru
e
includ
bovin
enteroviru
group
ev
ev
speci
enteroviru
f
includ
bovin
enteroviru
group
b
present
six
type
describ
ev
ev
speci
enteroviru
g
consist
sero
type
ev
ev
speci
enteroviru
h
includ
three
monkey
virus
isol
plaqu
viru
howev
four
virus
join
singl
sero
type
enteroviru
ev
due
strong
similar
molecular
level
speci
enteroviru
j
contain
six
simian
enteroviru
speci
ev
ev
ev
ev
ev
speci
rhinoviru
numer
contain
sero
type
rhinoviru
rv
rv
virus
belong
speci
rhinoviru
c
despit
differ
rhinoviru
rhinoviru
b
recent
difficulti
misunderstand
classif
discrimin
individu
type
within
speci
author
basi
numer
test
consid
virus
close
relat
rhinoviru
call
hrv
other
pre
fer
refer
virus
hrv
c
hrv
x
sinc
base
signific
phylogenet
clu
tere
consid
enteroviru
speci
reason
suggest
appear
creat
genet
base
system
would
allow
discrimin
type
similarli
sero
type
enteroviru
speci
speci
consist
sero
type
addit
genu
includ
sever
yet
unclassi
fie
enterovirus
one
monkey
enteroviru
sv
assign
certain
speci
genom
sequenc
ev
ev
match
exist
speci
thu
genu
enteroviru
includ
mani
virus
includ
highli
danger
human
time
virus
widespread
highli
resist
ant
action
physicochem
factor
begin
enterovir
infect
human
classifi
acut
respiratori
diseas
caus
intestin
virus
gener
accept
discrimi
nate
infect
caus
poliovirus
certain
sero
type
enteroviru
c
separ
group
call
poliomyel
review
poliovirus
current
posit
viral
taxonomi
diseas
caus
known
alreadi
ancient
egypt
german
orthopedist
jacob
von
hein
discrimin
poliomyel
separ
diseas
swedish
pediatrician
medin
suggest
infecti
natur
diseas
base
epidem
dissemin
pattern
poliomyel
mainli
affect
children
year
old
unfortun
antivir
drug
poliomyel
treatment
prevent
possibl
diseas
sever
clinic
form
abort
form
proce
symptom
nervou
system
damag
form
poliomyel
call
minor
ill
pass
rel
gentli
last
around
one
week
end
recoveri
nonparalyt
form
serou
mening
caus
polioviru
diseas
proce
significantli
sever
abort
form
complet
set
mening
symptom
howev
also
pass
favor
patient
make
full
recoveri
paralyt
form
poliomyel
dan
gerou
mention
form
may
convert
paralyt
form
upon
advers
develop
diseas
howev
mention
form
develop
patient
diseas
may
proceed
rapidli
gener
paralysi
may
occur
within
hour
due
damag
central
nervou
system
recoveri
period
may
last
year
follow
math
stage
stabl
paralys
contractur
defor
mation
irrevers
paralysi
usual
leg
occur
one
patient
mortal
group
patient
reach
due
develop
paralysi
expans
respiratori
muscl
turn
paralyt
form
also
divid
sever
al
kind
form
spinal
form
paralyt
poliomyel
common
character
lesion
predominantli
lumbar
section
spinal
cord
cervic
section
damag
less
often
howev
lesion
cervi
cal
thorac
section
spinal
cord
sever
may
caus
paralysi
respiratori
muscl
thu
disturb
respir
danger
respect
diaphragmat
paralysi
pontin
form
occur
upon
lesion
bridg
varoliu
isol
accompani
damag
spinal
cord
pontospin
form
medulla
pontobulbar
form
character
facial
muscl
paralysi
patient
make
full
recoveri
begin
day
diseas
bulbar
form
occur
case
paralyt
poliomyel
case
bulbar
glossopharyng
nerv
affect
diseas
proce
rapidli
character
seriou
gener
condit
fast
develop
paralysi
correspond
muscl
group
typic
pharyng
paralysi
lesion
palat
larynx
may
develop
lead
disturb
respira
tion
upper
airway
obstruct
saliva
mucu
sputum
earlier
pharyng
form
poliomyel
character
high
mortal
present
howev
pharyng
paralysi
may
good
prognosi
recoveri
without
consequ
treat
due
time
correctli
patient
pharyng
paralysi
combin
disord
spinal
oblongata
develop
collater
laryng
paralysi
lesion
larynx
ligament
possibl
acut
form
paralysi
caus
sudden
asphyxi
cyanosi
respiratori
center
may
affect
bulbar
poliomyel
result
disturb
breath
rhythm
frequenc
appear
breath
patholog
breath
disord
accompani
vasomotor
veget
disord
earli
lesion
vasomotor
center
may
caus
death
due
sudden
decreas
arteri
pressur
cardiac
arrest
approxim
half
lethal
case
evok
form
poliomyel
acut
interstiti
myocard
regist
rare
encephalit
form
poliomyel
high
mortal
also
describ
form
proce
rapidli
mental
confus
develop
fast
tran
form
stupor
coma
poliomyel
pregnant
patient
consid
sep
arat
first
half
pregnanc
diseas
may
caus
miscarriag
preterm
birth
infect
occur
later
howev
women
infect
poliomyel
pregnanc
give
birth
due
time
without
obstetr
surgeri
typic
fetu
affect
intox
hypoxia
rather
direct
transmi
sion
infect
respiratori
disord
pose
ele
vate
threat
remain
even
acut
phase
diseas
pass
pregnant
woman
well
poliomyel
outbreak
widespread
end
centuri
middl
centu
ry
anti
poliomyel
vaccin
appear
wide
use
world
health
organ
set
task
elimin
poliomyel
worldwid
activ
prevent
measur
wide
use
vac
cine
decreas
incid
level
current
high
risk
poliomyel
outbreak
remain
afghanistan
pakistan
new
strateg
plan
elimin
poliomyel
present
global
vaccin
summit
abu
dhabi
unit
arab
emir
first
reliabl
mention
diseas
caus
non
polio
enterovir
infect
occur
exactli
year
outbreak
pleurodynia
iceland
describ
later
first
pub
licat
devot
ill
date
norwegian
medic
journal
first
publish
communica
tion
dr
daae
dr
c
homann
titl
epidem
acut
muscular
rheumat
transmit
air
dranged
norwegian
name
ill
bambl
diseas
place
first
appear
later
refer
bornholm
diseas
danish
island
bornholm
wherea
known
epi
demic
myalgia
normal
diseas
caus
cox
sackieviru
b
infect
rare
may
caus
coxsackievirus
certain
sero
type
echoviru
evok
myositi
upper
abdomin
muscl
pector
muscl
fever
headach
typic
prognosi
posit
patient
recov
day
howev
possibl
sever
complic
includ
ing
though
rare
asept
mening
lethal
come
viral
myopericard
combin
myocardi
ti
pericard
involv
inflamm
cardiac
muscl
serou
layer
pericardium
infant
typic
myocard
develop
wherea
peri
carditi
common
children
adult
incorrect
late
treatment
may
result
death
frequent
caus
myopericard
coxsackieviru
b
infect
coinfect
coxsackievirus
b
echovirus
may
also
evok
disord
diseas
may
proceed
without
symptom
accompa
nie
chest
pain
vertigo
gener
weak
arrhyth
mia
heart
failur
fever
diarrhea
sore
throat
swell
hand
leg
may
also
occur
sometim
myopericard
caus
sudden
loss
con
scious
may
associ
abnorm
heart
rhythm
breath
difficulti
may
occur
children
viral
myopericard
may
convert
acut
myocardi
infarct
acut
hemorrhag
conjunct
enterovir
hemorrhag
conjunct
highli
contagi
oph
thalmic
infect
first
appear
proce
visibl
hyperemia
chemosi
eye
irrit
photophobia
eye
discharg
subconjuncti
val
hemorrhag
symptom
appear
along
gen
eral
symptom
preauricular
adenopathi
headach
increas
bodi
temperatur
tracheobronch
etc
recoveri
occur
day
caus
agent
acut
hemorrhag
conjunct
enteroviru
coxsackieviru
frequent
manifest
enterovir
infect
nonspecif
febril
ill
usual
infect
well
toler
pass
within
week
diseas
may
proceed
two
phase
acut
respirato
ry
viral
infect
arvi
also
ascrib
low
hazard
enterovir
infect
caus
rhinovirus
known
nasopharyng
rhinopharyng
rhinoviru
infec
tion
rhinonasopharyng
epipharyng
com
mon
cold
howev
respiratori
enterovir
infect
instanc
caus
enteroviru
may
lead
seriou
consequ
result
sever
com
plicat
pneumonia
asept
mening
viral
infecti
diseas
affect
human
age
howev
individu
year
old
suscept
common
caus
diseas
non
polio
enterovirus
name
coxsackievirus
b
echovirus
enterovirus
infect
mening
affect
patient
suffer
headach
fever
muscl
ach
stomach
ach
stiff
neck
possibl
symptom
light
sensit
rush
nausea
diarrhea
sore
throat
cough
rule
ill
good
prognosi
pass
without
consequ
day
howev
especi
newborn
infect
may
develop
symptom
enceph
focal
neurolog
ic
sign
cramp
case
prognosi
may
poor
lethal
outcom
caus
heart
failur
liver
damag
infecti
damag
central
nerv
ou
system
children
may
associ
also
enteroviru
case
diseas
proce
sever
form
may
evok
paresi
brainstem
enceph
herpangina
acut
infecti
diseas
caus
mainli
coxsackievirus
affect
year
biochemistri
moscow
vol
old
children
diseas
may
caus
also
enteroviru
distinct
symptom
pangina
appear
vesicl
serou
content
soft
palat
tonsil
back
throat
small
resembl
herpet
damag
usual
vesicl
open
rapidli
dri
crust
format
heal
upon
bacteri
coinfect
may
suppur
ulcer
ate
diseas
proce
gener
symptom
fever
headach
rhiniti
hypersaliv
sever
sore
throat
hyperemia
pain
palpat
region
lymph
node
diseas
usual
pass
day
enterovir
vesicular
stomat
hand
foot
mouth
diseas
hfmd
acut
diseas
caus
coxsackievirus
b
enteroviru
predomi
nantli
occur
children
year
old
howev
may
also
affect
adult
incub
period
last
approxim
day
prodrom
period
h
patient
exp
rienc
symptom
cough
sore
throat
gener
ill
ness
loss
appetit
vesicular
rash
appear
hand
leg
oral
caviti
diseas
goe
auspici
end
day
howev
sometim
especi
infect
caus
enteroviru
may
lead
sever
neurolog
complic
enceph
mening
paralys
like
caus
polioviru
form
highli
sever
featur
high
mortal
seven
million
case
regist
china
fatal
case
enterovir
enceph
amount
approxim
case
enterovir
infect
main
caus
sever
neurolog
diseas
coxsackievirus
b
echovirus
enteroviru
diseas
involv
inflamm
brain
accompa
nie
fever
vomit
headach
weak
disord
conscious
cramp
behavior
disord
paresi
may
occur
sever
diseas
may
result
coma
acut
cerebellar
ataxia
drop
attack
hemichorea
may
occur
children
sever
clinic
type
enterovi
ral
enceph
discrimin
accord
localiza
tion
inflamm
brainstem
cerebellar
hemispher
cerebellar
form
auspici
end
full
recoveri
howev
enterovir
enceph
deadli
diseas
enceph
caus
enteroviru
infect
usual
brainstem
clinic
featur
high
mortal
polio
like
ill
acut
flaccid
paralysi
acut
paralyt
poliomyel
non
polio
etiolog
diseas
symptom
similar
poliomyel
caus
virus
name
enterovirus
cox
sackievirus
echovirus
diseas
affect
predominantli
children
sever
form
commonli
caus
enteroviru
lesion
central
nervou
system
occur
develop
sever
form
diseas
similarli
poliomyel
may
evok
seriou
consequ
includ
fatal
come
enterovir
infect
danger
human
mani
anim
speci
suscept
virus
especi
higher
mammal
enterovir
infec
tion
anim
may
worsen
life
pet
even
caus
signific
damag
entir
branch
agricultur
asso
ciat
livestock
farm
case
sever
gastroen
teriti
caus
enterovir
infect
lead
mortal
young
stock
regist
poultri
farm
bird
livestock
farm
suffer
outbreak
enterovir
infect
caus
high
mortal
farm
ani
mal
instanc
pig
addit
entir
popula
tion
rare
endang
speci
becom
victim
infecti
diseas
even
dolphin
suscept
infect
thu
counteract
spread
diseas
great
import
earli
diagnosi
enterovir
infect
follow
antivir
therapi
may
prevent
occurr
sever
com
plicat
patient
howev
highli
effici
wide
use
anti
enterovir
prepar
therefor
treatment
enterovir
infect
limit
complex
procedur
reliev
gener
con
dition
patient
counteract
concomit
bacteri
infect
minim
possibl
complic
viral
infect
must
dealt
immun
sy
tem
patient
therefor
great
need
develop
highli
effici
antivir
agent
treat
ment
enterovir
infect
life
cycl
enterovirus
includ
viru
adsorp
tion
releas
genet
materi
envelop
rna
translat
matur
viral
protein
replic
viral
rna
viru
assembl
stage
target
antivir
agent
enteroviru
envelop
consist
four
viral
pro
tein
one
frequent
use
target
counteract
enterovir
infect
great
number
chemic
compound
antivir
proper
tie
vitro
interact
prevent
viru
adsorpt
releas
viral
rna
envelop
one
success
experi
design
antivir
prepar
interact
viral
envelop
pleconaril
inhibit
replica
tion
sever
enterovir
sero
type
though
affect
ev
demonstr
intak
drug
allevi
diseas
passag
although
prepar
numer
neg
side
effect
pass
clinic
trial
yet
serv
basi
develop
effici
less
toxic
antivir
drug
prepar
base
drug
interact
viral
capsid
pass
clini
cal
trial
due
side
effect
also
develop
biochemistri
moscow
vol
viral
proteas
also
target
drug
design
protein
proteas
picornavirus
play
import
role
process
viral
polyprotein
addit
affect
host
cap
depend
protein
synthesi
cleav
elong
factor
disturb
nuclear
transport
impair
cellular
splice
transcript
success
propag
mani
virus
depend
correct
process
viral
polyprotein
instanc
polyprotein
ev
cleav
viral
proteas
give
rise
four
structur
envelop
protein
seven
nonstructur
protein
requir
viru
replic
translat
proteas
cleav
n
terminu
c
terminu
thu
separ
capsid
protein
precursor
precursor
replic
protein
howev
proteas
consid
main
viral
proteas
respons
cleav
linker
join
protein
viral
polyprotein
shown
alkyl
agent
iodoacetamid
n
ethylmaleimid
reduc
activ
proteas
caspas
inhibitor
also
may
block
proteas
rhinovirus
coxsackieviru
vitro
vivo
antivir
agent
affect
proteas
obtain
base
substrat
proteas
mani
peptid
compris
amino
acid
residu
aa
aldehyd
group
use
elec
trophil
anchor
peptid
inhibitor
proteas
modifi
could
form
irr
versibl
coval
bond
proteas
agent
possess
high
antivir
activ
toward
rhinovirus
cv
cv
ev
echoviru
known
alkaloid
antivir
prop
erti
lycorin
alkaloid
famili
amaryllidacea
broad
spectrum
biolog
activ
inhibit
develop
poliovirus
ev
affect
particular
proteas
rupintrivir
initi
design
inhibitor
rhinovir
proteas
later
demonstr
antivir
activ
toward
repres
famili
picornavirida
deriv
prepar
also
abl
inhibit
enterovirus
ev
cv
follow
group
includ
antivir
drug
affect
ing
viral
protein
involv
replic
viral
rna
cell
system
use
virus
rna
replic
replic
viral
rna
occur
particip
replic
complex
compris
variou
viral
protein
test
target
antivir
agent
prepara
tion
obtain
featur
narrow
activ
spectrum
also
side
effect
exampl
dichlorophenyl
methylhydantoin
hydantoin
deriva
tive
inhibit
replic
ev
rna
exact
mechan
effect
studi
appar
process
viral
rna
replic
disturb
due
interact
prepar
capsid
protein
thu
block
activ
protein
also
directli
interact
compound
bpr
bromo
dimethylphenyl
methyl
pyrazol
yl
quinolin
carboxyl
acid
interact
viral
rna
depend
rna
polymeras
inhibit
translat
ev
rna
alreadi
known
drug
frequent
possess
antivir
activ
affect
replic
viral
rna
instanc
isoflavon
formononetin
commonli
obtain
red
clover
antifung
broad
spectrum
prepar
itraconazol
besid
experi
carri
discoveri
antivir
prepar
base
noncod
regulatori
microrna
also
use
vaccin
prepar
promis
target
antivir
drug
intern
ribosom
entri
site
ire
viral
mrna
region
utr
viral
mrna
preiniti
complex
assembl
play
pivot
role
regul
translat
viral
iress
differ
cellular
iress
presenc
highli
order
secondari
structur
set
factor
use
translat
initi
requir
ire
tran
act
factor
itaf
therefor
process
translat
initi
viral
mrna
promis
target
pharmacolog
action
besid
demonstr
mutat
ire
affect
interact
itaf
viral
mrna
also
affect
viral
tissu
tropism
iress
virus
may
act
chaperon
influenc
develop
viral
infec
tion
initi
translat
viral
mrna
soon
viral
iress
discov
attempt
made
use
therapi
main
effort
focus
develop
compound
would
abl
modifi
ire
structur
make
inelig
initi
protein
synthesi
disturb
interact
ribosom
translat
initi
factor
itaf
approach
associ
design
search
antivir
agent
whose
action
direct
iress
extens
develop
follow
com
pound
consid
prepar
basi
develop
complementari
oligonucleotid
peptid
nucleic
acid
lock
nucleic
acid
morpholin
short
rna
hairpin
small
interf
rna
rna
aptam
ribozym
dnazym
peptid
low
molecular
weight
inhibitor
histor
first
agent
direct
iress
complementari
oligonucleotid
major
earli
attempt
made
prevent
hepat
c
viru
gene
express
biochemistri
moscow
vol
two
approach
appli
work
one
approach
use
complementari
dna
oligonucleotid
target
rnase
h
cleavag
second
approach
con
sist
design
dna
oligonucleotid
would
block
interact
ire
ribosom
unfortun
latter
approach
sever
typic
di
advantag
associ
effici
transport
dna
oligonucleotid
intracellular
stabil
certain
case
neg
side
effect
improv
stabil
affin
complementari
dna
oligonucleotid
modifi
analog
develop
consist
peptid
nucleic
acid
lock
nucleic
acid
howev
solv
problem
deliveri
intracellular
transport
toxic
compound
develop
approach
attent
research
drawn
morpholin
singl
strand
dna
like
cell
penetr
complementari
agent
abl
decreas
level
gene
express
block
compl
mentari
rna
sequenc
repres
third
genera
tion
complementari
oligonucleotid
featur
accept
toxic
resist
nucleas
morpholinorna
duplex
significantli
stabl
similar
dnarna
duplex
morpholin
steric
ly
block
target
rna
wide
use
modul
express
gene
certain
organ
frog
zebrafish
set
peptid
conjug
pho
phorodiamid
morpholino
oligom
ppmo
design
complementari
conserv
type
ire
region
rna
virus
rhinoviru
coxsack
ieviru
polioviru
type
com
pound
solubl
water
resist
action
nucleas
effici
penetr
cell
inhibit
viru
replic
form
duplex
compl
mentari
viral
mrna
cell
cultur
reduc
viru
titer
sever
order
magnitud
applic
ppmo
increas
surviv
mice
infect
polioviru
coxsackieviru
ebola
viru
influenza
viru
octa
guanidin
conjug
morpholin
vivo
morpholino
vpmo
also
singl
strand
dna
like
complementari
agent
shown
com
pound
reduc
rna
replic
express
capsid
protein
ev
viru
besid
com
pound
inhibit
develop
polioviru
coxsack
ieviru
singl
strand
mrna
region
potenti
avail
bind
prefer
target
design
com
plementari
antivir
agent
use
mention
technolog
region
usual
locat
within
apic
loop
variou
hairpin
bulg
element
rna
secondari
structur
anoth
kind
antivir
drug
rna
hairpin
small
interf
rna
sirna
upon
transfec
tion
polioviru
infect
murin
fibroblast
sirna
strong
inhibit
polioviru
replic
occur
though
sirna
might
use
basi
devel
opment
medic
suffer
cell
tran
port
problem
mention
drug
furthermor
rna
agent
carri
net
neg
charg
less
stabl
imped
deliveri
cell
overcom
problem
liposom
polymer
nanoparticl
use
drug
deliveri
vehicl
besid
sirna
suffer
signific
disadvantag
activ
protein
kinas
k
inhibit
transla
tion
cellular
protein
due
phosphoryl
subunit
translat
initi
factor
therefor
approach
base
use
dna
oligonu
cleotid
agent
current
consid
promis
agent
featur
higher
intracellular
stabil
increas
affin
toward
target
viral
rna
next
kind
antivir
drug
ribozym
dnazym
ribozym
conjug
rna
aptam
dnazym
catalyt
dna
cleav
pho
phodiest
bond
rna
molecul
obtain
easili
synthet
ribozym
stabl
unlik
sirna
dnazym
acti
vate
protein
kinas
k
ribozym
dnazym
specif
inhibit
viral
iress
rep
resent
reason
basi
develop
therapeut
prepar
direct
virus
use
ire
depend
translat
initi
peptid
inhibitor
small
molecul
extens
ly
use
medicin
peptid
usual
consist
aa
mimic
function
activ
region
intact
protein
serv
basi
design
due
small
size
specif
bind
target
rna
disrupt
function
complex
form
alreadi
sever
peptid
design
block
ire
hepat
c
viru
base
rna
recognit
motif
la
autoantigen
prevent
bind
la
ire
hepat
c
viru
howev
la
also
itaf
numer
viral
cellular
iress
therefor
peptid
specif
hepat
c
viru
solv
problem
intracellular
peptid
resist
anc
proteolysi
unnatur
amino
acid
intro
duce
correspond
compound
refer
peptidomimet
liposom
polym
ic
nanoparticl
use
deliveri
peptid
cell
also
peptid
link
protein
domain
assist
transmembran
transport
altern
may
synthes
cell
upon
transduct
viral
vector
gene
therapi
current
small
molecul
prefer
drug
new
approach
direct
toward
gener
librari
small
molecul
desir
properti
use
combinatori
chemistri
larg
librari
gener
ate
close
relat
structur
analog
test
biolog
screen
numer
attempt
made
small
molecul
abl
deactiv
viral
iress
result
potenti
low
molecular
weight
antivir
agent
obtain
biochemistri
moscow
vol
instanc
shown
aminoacridin
deriva
tive
quinacrin
inhibit
translat
polioviru
cell
free
system
infect
hela
cell
make
prospect
studi
mole
cule
becom
subject
clinic
trial
howev
despit
failur
approach
still
consid
one
prospect
one
summar
said
note
despit
sever
promis
direct
action
antivir
prepara
tion
includ
one
alreadi
approv
medic
applic
worldwid
certifi
commonli
recogn
antivir
drug
treatment
di
eas
caus
enterovirus
physician
forc
counteract
consequ
diseas
rather
caus
thu
valuabl
time
lost
increas
risk
irr
versibl
damag
patient
current
effi
cient
remedi
enterovir
infect
prevent
joint
global
effort
direct
may
provid
great
outcom
like
reach
fight
poliomyel
reason
vaccin
danger
repr
sent
genu
enteroviru
develop
extens
nevertheless
despit
reduct
infect
case
global
effort
toward
elimina
tion
poliomyel
diseas
persist
time
one
clearli
recogn
still
singl
polioviru
infect
individu
unvaccin
peo
ple
worldwid
risk
infect
mention
develop
antivir
drug
associ
signific
difficulti
scientif
one
also
organiz
financi
dif
ficulti
global
scale
effici
prevent
must
ubiquit
constant
still
problem
besid
vaccin
usual
highli
specif
wherea
enterovirus
divers
furthermor
cer
tain
condit
vaccin
may
lead
neg
event
vaccin
born
viru
infect
occur
overal
success
fight
poliomyel
main
point
prevent
help
alreadi
infect
may
reli
immun
system
symptomat
treatment
therefor
urgent
need
design
drug
directli
affect
enterovirus
caus
numer
danger
diseas
clear
drug
wide
spectrum
specif
esp
cialli
requir
would
allow
suppress
enteroviru
epidem
begin
spread
develop
prepar
car
rie
worldwid
